CASTRATE-SENSITIVE

Clinical trials for CASTRATE-SENSITIVE explained in plain language.

Never miss a new study

Get alerted when new CASTRATE-SENSITIVE trials appear

Sign up with your email to follow new studies for CASTRATE-SENSITIVE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 1

Veterans study pits three prostate cancer drugs Head-to-Head

Disease control Recruiting now

This study aims to find which of three drugs—abiraterone, enzalutamide, or apalutamide—works best as a first treatment for veterans with prostate cancer that still responds to hormone therapy. About 192 veterans will be randomly assigned to one of the drugs, and researchers will …

Matched conditions: CASTRATE-SENSITIVE

Phase: PHASE2 • Sponsor: Sun Pharmaceutical Industries Limited • Aim: Disease control

Last updated Jun 22, 2026 12:09 UTC

CASTRATE-SENSITIVE

Get alerted when new CASTRATE-SENSITIVE trials appear

Veterans study pits three prostate cancer drugs Head-to-Head